A5086189625- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Hepatocellular Carcinoma Treatment and Prognosis
- Cardiac, Anesthesia and Surgical Outcomes
- Gastric Cancer Management and Outcomes
- Neuroendocrine Tumor Research Advances
- Liver Disease Diagnosis and Treatment
- Lung Cancer Research Studies
- Colorectal Cancer Surgical Treatments
- Cancer, Lipids, and Metabolism
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
- Viral-associated cancers and disorders
- Healthcare Policy and Management
- Enhanced Recovery After Surgery
- Colorectal Cancer Screening and Detection
- Pancreatitis Pathology and Treatment
- Liver Disease and Transplantation
- Genetic factors in colorectal cancer
- Hip and Femur Fractures
- Metastasis and carcinoma case studies
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal and Anal Carcinomas
- Economic and Financial Impacts of Cancer
The Ohio State University Wexner Medical Center
2019-2025
Yokohama City University
2019-2025
Saiseikai Ibaraki Hospital
2023
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
2019-2022
Fujisawa City Hospital
2022
European Neuroendocrine Tumor Society
2019
Liaquat National Hospital
2019
The Ohio State University
2019
Duke University
2019
Johns Hopkins University
2019
Although surgery offers the best chance of a potential cure for patients with localized, resectable intrahepatic cholangiocarcinoma (ICC), prognosis remains dismal largely because high incidence recurrence.To predict very early recurrence (VER) (ie, within 6 months after surgery) following resection ICC in pre- and postoperative setting.Patients who underwent curative-intent between May 1990 July 2016 were identified from an international multi-institutional database. The study was conducted...
Abstract Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system has been largely adopted in clinical practice, recent studies have emphasized need for further refinement and subclassification of this system. Methods Patients who underwent hepatectomy with curative intent BCLC-0, -A or -B hepatocellular carcinoma (HCC) between 2000 2017 were identified using a multi-institutional database. The tumour burden score (TBS) was calculated, overall survival (OS) examined...
Objective: The objective of the current study was to define surgical outcomes after resection multinodular hepatocellular carcinoma (HCC) beyond Milan criteria, and develop a prediction tool identify which patients likely benefit most from resection. Background: Liver for HCC, especially remains controversial. Rigorous selection best candidates is essential achieve optimal liver advanced tumors. Methods: Patients who underwent HCC between 2000 2017 were identified an international...
Abstract Background The feasibility of trials in liver surgery using a single-component clinical endpoint is low because single endpoints require large samples due to their incidence. current study sought develop and validate novel composite (CELS) facilitate the generation more feasible robust high-level evidence field surgery. Methods Patients who underwent curative-intent hepatectomy for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or colorectal metastasis were identified...
The objective of the current study was to define impact albumin-bilirubin (ALBI) grade on short- as well long-term outcomes among patients with intrahepatic cholangiocarcinoma (ICC).Patients who underwent hepatectomy for ICC between 1990 and 2016 were identified using an international multi-institutional database. Clinicopathologic factors including ALBI score assessed bivariate multivariable analyses, standard survival analyses.Among 706 patients, 453 (64.2%) had 1, 231 (32.7%) 2, 22 (3.1%)...
The objective of the current study was to define and compare rates textbook outcomes (TO) among patients undergoing colorectal, lung, esophagus, liver, pancreatic surgery for cancer at U.S. News & World Report (USNWR) ranked hospitals.Medicare Inpatient Standard Analytic Files 2013-2015 were utilized examine relationship TO USNWR hospital ratings following esophageal, pancreatic, liver cancer. defined as no postoperative surgical complications, prolonged length stay, readmission within 90...
Liver resection for multifocal intrahepatic cholangiocarcinoma (ICC) remains controversial due to a poor prognosis, driven by aggressive tumour biology. The aim of this study was stratify ICC patients identify those who are likely benefit from resection. Patients underwent upfront curative-intent hepatectomy were identified an international multi-institutional database. Among with tumours, overall survival (OS) analysed using multivariable Cox regression prognostic factors. Tumour burden...